We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immune Pharma Announces Exclusive License

News   Jan 04, 2016

 
Immune Pharma Announces Exclusive License
 
 
 

RELATED ARTICLES

Ribosome-based Treatments: A Sought After Therapy Option for Orphan Diseases?

News

Recently, Urania Therapeutics announced that it has successfully raised €3.53M ($3.89M) in seed funding to unlock the therapeutic potential of ribosome-based treatments. We spoke with Jean-Paul Renaud, President and CSO of Urania Therapeutics, to learn more about the mechanisms of readthrough compounds and how the company hopes to provide treatment solutions for orphan diseases.

READ MORE

Vaccine Could Stop Spread of Bovine TB

News

A novel vaccine and complementary skin test to protect cattle against bovine tuberculosis (bovine TB) have been developed, that could save many from culling.

READ MORE

GlycoPRIME: Accelerating Protein Therapeutic Development

News

Northwestern Engineering researchers have now developed a quick, cell-free system to build and study biosynthetic pathways. Called GlycoPRIME, the system could lead to faster development of therapeutics and a new, modular way to make medicines on demand in resource-limited settings.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE